Role of Live-JSLM in Treating Recurrent CDI

Joseph Reilly, BS, PharmD, BCGP, and Andrew Skinner, MD, discuss the potential benefits of using live-jslm early on to treat CDI, as well as the implications of this new treatment.

Related Videos
Glenn S. Tillotson, PhD: Treating Immunocompromised Patients With RBX2660
Related Content
© 2023 MJH Life Sciences

All rights reserved.